or Try an Advanced Search...

    ETF Components for LABD - Direxion Daily S&P Biotech Bear 3X Shares


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    EXEL D 0.14 1.91
    BMRN D 0.81 1.89
    BLUE F 0.14 1.87
    VRTX B -1.19 1.84
    SAGE F 2.36 1.80
    UTHR A 2.21 1.78
    REGN A 1.70 1.77
    AMGN C 0.13 1.75
    ALNY C 1.67 1.73
    EXAS F 0.00 1.73
    ABBV B -0.96 1.72
    ACAD F 2.26 1.68
    SRPT D -1.15 1.66
    BIIB C 2.17 1.65
    IONS D 4.56 1.64
    GILD F -0.85 1.64
    NBIX D 1.10 1.62
    BPMC B 0.71 1.61
    INCY B 0.77 1.51
    RARE C 7.83 1.49
    MRNA C -0.45 1.47
    LGND C 0.06 1.46
    ARWR C 4.59 1.45
    BHVN F -1.34 1.42
    PTCT B -0.05 1.40
    FOLD D 2.31 1.38
    AGIO B 0.97 1.37
    APLS F -0.58 1.24
    ALKS D 0.20 1.21
    MYGN B 4.85 1.08
    NTRA B 0.12 1.08
    IOVA F -1.04 1.07
    FGEN F 2.65 1.05
    RGNX F -3.17 1.05
    DCPH A 0.00 1.01
    CHRS F 5.20 0.99
    EBS C -2.47 0.96
    CDNA B 2.69 0.93
    HRTX C 0.55 0.84
    INSM B -0.36 0.81
    KPTI F 1.98 0.79
    ESPR B -0.34 0.79
    ALLK D -0.78 0.76
    IRWD F 2.08 0.75
    VCYT C 3.66 0.72
    HALO B -0.52 0.71
    FATE F -3.08 0.67
    EDIT D 11.23 0.66
    PBYI F 3.60 0.65
    MDGL B -2.11 0.59
    TGTX C 4.09 0.55
    ADVM F 7.66 0.55
    ALLO F 0.78 0.54
    CPRX C -0.71 0.53
    ANAB B 1.90 0.53
    XNCR C 0.36 0.49
    SGMO C -0.87 0.48
    ENTA D -0.97 0.47
    EGRX F -0.27 0.42
    GTHX F 0.35 0.42
    ATRA F -3.06 0.41
    VKTX D -0.51 0.38
    ANIK B 0.93 0.37
    VNDA B -1.17 0.35
    OPK C -0.76 0.35
    VCEL D 0.48 0.34
    TVTX D 3.82 0.33
    KOD F -1.06 0.29
    BBIO C 4.37 0.29
    NTLA D 8.84 0.29
    PGEN B 1.83 0.29
    DNLI B -0.28 0.28
    KRYS B 2.52 0.28
    GOSS F 1.96 0.27
    VYGR C 0.00 0.26
    MGNX F 1.22 0.25
    ALEC F 6.33 0.25
    CYTK F 1.41 0.25
    DVAX C 0.08 0.24
    YMAB D 0.08 0.24

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Chemical Compounds Inflammation Clinical Medicine Disease Immune System Immunology S&P 500 Cholesterol Genetics Infectious Diseases Monoclonal Antibody Nasdaq 100 Organ Systems
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Diagnostics & Research

    Recent News for Direxion Daily S&P Biotech Bear 3X Shares & its Holdings

    Date Stock Title
    Jun 12 RARE Ultragenyx to file for accelerated approval of rare metabolic disease candidate
    Jun 12 RARE Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    Jun 12 RARE Ultragenyx Announces Plans to File for Accelerated Approval of UX111 for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)
    Jun 12 MDGL Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
    Jun 12 ALNY Citi opens upside catalyst watch on Alnylam ahead of ATTR-CM data
    Jun 12 RARE Ultragenyx (RARE) Posts New Data From Bone Disease Study
    Jun 12 SAGE SAGE's Huntington's Disease Study Meets Primary Endpoint
    Jun 12 RARE Mereo spikes after mid-stage data for Ultragenyx-partnered bone disorder therapy
    Jun 12 REGN Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
    Jun 12 MDGL Madrigal Pharmaceuticals: The GLP-1 Threat May Be Overcooked
    Jun 12 AMGN Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
    Jun 12 GILD How Luciana Preger Is Helping Advance Gilead’s Work in Oncology
    Jun 12 AMGN AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
    Jun 12 RARE Ultragenyx, Mereo drug reduces fractures in bone disorder study
    Jun 12 VRTX 2 Healthcare Stocks to Buy Hand Over Fist in June
    Jun 12 AGIO Agios Pharmaceuticals: Potential Acquisition Target, Upcoming FDA Approvals, Promising Pipeline
    Jun 12 RGNX REGENXBIO names new chief executive
    Jun 12 NBIX Those who invested in Neurocrine Biosciences (NASDAQ:NBIX) five years ago are up 55%
    Jun 12 RGNX REGENXBIO Announces Leadership Transition
    Jun 12 ATRA Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
    The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF S&P 500 Index CBOE Inverse ETF Bear Market ETF Repurchase Agreement Financial Regulation Forward Contract
    Back to the Main LABD Page...